GeneDx Holdings Corp.
WGSNASDAQHealthcareDiagnostics & Research
As of Oct 23, 2026 close
- Market cap
- $1.67B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $32.21$170.87
- Volume (live)
- -
- Avg. volume (3M)
- 848.01K
GeneDx Holdings (WGS) Stock Price & Financial Analysis
GeneDx Holdings Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $55.00 - $67.40 |
|---|---|
| 52-Week High | $170.87 |
| 52-Week Low | $32.21 |
| Open | $67.20 |
| Volume (last close) | 2.56M |
| Average Volume (3M) | 848.01K |
| Revenue (TTM) | 454.43M |
|---|---|
| Net Income (TTM) | -106.36M |
| Free Cash Flow (TTM) | -75.80M |
| EPS (TTM) | −$3.64 |
| Profit Margin | -23.40% |
| Operating Margin | -19.85% |
| Return on Equity (ROE) | -43.55% |
| Debt to Equity | 0.69 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 1.67B |
|---|---|
| Shares Outstanding | 29.71M |
| Price to Sales (P/S) | 3.67 |
| Price to Book (P/B) | 6.83 |
| EV/EBITDA | -62.06 |
| 50-Day MA | $81.37 |
|---|---|
| 200-Day MA | $74.37 |
| 1-Year Change | −46.32% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
GeneDx Holdings at a Glance
As of the Oct 23, 2026 close, GeneDx Holdings (WGS) has a market capitalization of $1.67B. The stock trades at 3.7× sales. Over the trailing twelve months it lost $106.36M on revenue of $454.43M and burned $75.80M of free cash flow. Revenue grew 25.4% year over year.
As of its latest reported balance sheet, it holds $60.32M in cash and securities against $167.40M of debt, a net debt position of $107.08M.
GeneDx Holdings does not currently pay a dividend.
The share price is down 46.3% over the past year. At $56.15 (the Oct 23, 2026 close) it sits within its 52-week range of $32.21 to $170.87, below its 200-day moving average of $74.37.
Based on 8 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $88.50, 57.6% above the Oct 23, 2026 close.
Frequently Asked Questions About GeneDx Holdings
What is the current stock price for WGS?
As of the Oct 23, 2026 close, WGS stock trades at $56.15. The 52-week range is $32.21–$170.87, with a day range of $55.00–$67.40.
What is the P/E ratio for WGS?
The P/E ratio (Price-to-Earnings) for WGS is shown in the Key Statistics section. This valuation metric helps compare GeneDx Holdings Corp. to industry peers.
Does WGS pay dividends?
GeneDx Holdings does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for WGS?
Based on ratings from 8 professional analysts over the last 90 days, the consensus for WGS is Buy. The average 12-month price target is $88.50, a 57.6% upside from the Oct 23, 2026 close of $56.15.
What is the market cap of WGS?
As of the Oct 23, 2026 close, GeneDx Holdings's market capitalization is $1.67B, classifying it as a small-cap company. GeneDx Holdings operates in the Healthcare sector within the Diagnostics & Research industry.